期刊文献+

归脾汤+舒血宁+昆仙胶囊联合西医治疗混合性结缔组织病合并慢性心功能不全1例报告

Guipi Decoction Plus Shuxuening+Kunxian Capsule combined with Western Medicine Treatment of Mixed Connective Tissue Disease Complicated with Chronic Heart Failure:Report of 1 Cases
下载PDF
导出
摘要 混合性结缔组织病合并慢性心功能不全累及全身多个器官,若不及时治疗,可导致患者死亡。报告1例经归脾汤+舒血宁+昆仙胶囊联合补充电解质、保护胃黏膜、强心、扩血管、控制心室率、改善肺动脉高压、利尿消肿、减轻心脏负荷及抗炎抑制免疫等治疗,病情稳定,逐步康复。重视早期积极治疗控制原发病,使其不向更为严重的方向发展,其并发症才可以从根本上得到缓解。辨证联合中药治疗,能够有效地增强激素作用,降低毒副作用,缓解临床症状。 Mixed connective tissue disease with chronic cardiac insufficiency involving multiple organs, if left untreated, can lead to death, we treated the disease patient by guipi soup+ shuxuening + kunxian capsule joint electrolytes, protecting gastric mucosa, Dilating blood vessels, strengthening heart, controling ventricular rate, improving pulmonary hypertension, Promoting urination, reducing heart load and its anti-inflammatory immune therapy, such as in a stable, condition and gradually recovered. Early aggressive treatment of the primary disease is very important to control the primary disease, so as not to more serious direction, its complications can be fundamentally relieved.Combined traditional Chinese medicine ( TCM ) syndrome differentiation treatment, can effectively enhance the hormone effect, reduce side effects, relieve the clinical symptoms.
作者 耿健 汲泓
出处 《实用中医内科杂志》 2014年第11期117-118,123,共3页 Journal of Practical Traditional Chinese Internal Medicine
关键词 混合性结缔组织病 慢性心功能不全 归脾汤 舒血宁 昆仙胶囊 中西医结合治疗 病例报告 Mixed connective tissue disease Chronic heart failure Guipi Decoction Shuxuening Kunxiancapsule Therapy of combining traditional Chinese and Western medicine Case report
  • 相关文献

参考文献5

  • 1Sharp GC, Irvin WG, et al.Mixed connective tissue disease:an apparently distinct rheumatic disease sydrome associated with a specific antibody to an extractable nuclear antigen ( ENA ) [ J ] .Am JMed, 1972, 52 (2): 148-159.
  • 2Hoffman RW, Bezruczko N, Perkins K.An external validation study of a classification of mixed connective tissue disease and systemic lupus erythematosus patients [ J ] .J Appl Meas, 2012, 13 ( 2 ) : 205-216.
  • 3陈灏珠.实用内科学[M].13版.北京:人民卫生出版社,2002:1632.
  • 4Enldennk F, Cats A.Fatal primary pulmonary hypertension in mixed connective tissue disease [ J ] .Z Rhumtol, 1998, 40 ( 2 ) : 25-29.
  • 5雷云霞,张晓.结缔组织病相关的肺动脉高压[J].岭南心血管病杂志,2012,18(5):460-462. 被引量:2

二级参考文献15

  • 1荆志成.2010年中国肺高血压诊治指南[J].中国医学前沿杂志(电子版),2011,3(2):62-81. 被引量:118
  • 2GALIE N,HOEPER M M,HUMBERT M. Guidelines for the diagnosis and treatment of pulmonary hypertension:the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS),endorsed by the International Society of Heart and Lung Transplantation (ISHLT)[J].European Heart Journal,2009,(20):2493-2537.
  • 3MCLAUGHLIN V V,ARCHER S L,BADESCH D B. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of the Chest Physicians; American Thoracic Society,Inc.; and the Pulmonary Hypertension Association[J].Journal of the American College of Cardiology,2009,(17):1573-1619.
  • 4British Cardiac Society Guidelines and Medical Practice Committee. Recommendations on the management of pulmonary hypertension in clinical practice[J].Heart,2001,(Suppl 1):I1-I13.
  • 5SIMONNEAU G,GALI(E) N,RUBIN L J. ClinicaI classification of pulmonary hypertension[J].Journal of the American College of Cardiology,2004,(12 Suppl S):5S-12S.doi:10.1016/j.jacc.2004.02.037.
  • 6MORSE J,BARST R,HORN E. Pulmonary hypertension in scleroderma spectrum of disease:lack of bone morphogenetic protein receptor 2 mutations[J].Journal of Rheumatology,2002,(11):2379-2381.
  • 7TAMBY M C,CHANSEAUD Y,HUMBERT M. Antiendothelial ceil antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension[J].Thorax,2005,(09):765-772.
  • 8STEEN V D,MEDSGER T. Changes in causes of death in systemic sclerosis,1972-2002[J].Annals of the Rheumatic Diseases,2007,(07):940-944.
  • 9MCGOON M,GUTTERMAN D,STEEN V D. Screening,early detection,and diagnosis of pulmonary arterial hypertension:ACCP evidence-based clinical practice guidelines[J].Chest,2004,(Suppl):14S-34S.
  • 10HOEPER M M,PLETZ M W,GOLPON H. Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension[J].European Respiratory Journal,2007,(05):944-950.

共引文献1

  • 1刘少庭,祝河霞,查方勇,徐军,李向波,周城林.方剂复合应用3例[J].实用中医内科杂志,2014,28(11):122-123.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部